Pfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday.
Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease , is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang Rattay/Illustration/File Photois working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday.Paxlovid to treat high-risk patients in several provinces.
"We are sending as much Paxlovid as we can, our manufacturing machines are working to be able to supply at this stage," Bourla said in the interview at the J.P Morgan Healthcare Conference.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer's Paxlovid not included in China's national insuranceTAIPEI, Taiwan (AP) — Chinese health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.
Read more »
China says talks to include Paxlovid in state health insurance failChina's Health Security Administration said on Sunday that talks to include Pfizer's Paxlovid in the latest drug list for basic state health insurance did not succeed.
Read more »
China says talks to include Paxlovid in its insurance drug list failChina will not include Pfizer Inc's Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as the U.S. firm quoted a high price for the COVID-19 drug, China's Healthcare Security Administration (NHSA) said on Sunday.
Read more »
Solana soars 22%, and court docs reveal DOJ seized FTX-linked Robinhood shares: CNBC Crypto WorldCNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what's ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry. On today's show, George Kaloudis, a research analyst for CoinDesk, discusses the findings of a report highlighting crypto's progress last year and how the FTX collapse impacted markets.
Read more »
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medicationThe U.S. Supreme Court on Monday turned away Pfizer Inc's bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition after federal officials found that the drugmaker's arrangement could amount to illegal kickbacks.
Read more »
China suspends social media accounts criticizing COVID policiesChina has removed more than 1,000 social media accounts for criticizing the government's COVID-19 policies, BBC reports.
Read more »